Tearsheet

Cadre (CDRE)

Market Price (12/30/2025): $41.87 | Market Cap: $1.7 Bil
Sector: Industrials | Industry: Aerospace & Defense

Cadre (CDRE)

Market Price (12/30/2025): $41.87
Market Cap: $1.7 Bil
Sector: Industrials
Industry: Aerospace & Defense

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0	Strong revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 20%	Weak multi-year price returns 2Y Excs Rtn is -13%	Key risks CDRE key risks include [1] heightened regulatory and product liability exposure from its specialized safety products and [2] demand volatility tied to fluctuating government budgets.
1	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 11%
2	Low stock price volatility Vol 12M is 43%
3	Megatrend and thematic drivers Megatrends include Digital & Alternative Assets, and Smart Buildings & Proptech. Themes include Private Real Estate Investment Platforms, and Proptech Platforms.

0	Strong revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 20%
1	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 11%
2	Low stock price volatility Vol 12M is 43%
3	Megatrend and thematic drivers Megatrends include Digital & Alternative Assets, and Smart Buildings & Proptech. Themes include Private Real Estate Investment Platforms, and Proptech Platforms.
4	Weak multi-year price returns 2Y Excs Rtn is -13%
5	Key risks CDRE key risks include [1] heightened regulatory and product liability exposure from its specialized safety products and [2] demand volatility tied to fluctuating government budgets.

Valuation, Metrics & Events

	12/30/25	2024	2023	2022	2021
Share Price CYE	$41.87	$31.96	$32.21	$19.46	$24.24
Market Cap CYE ($ Bil)	1.7	1.3	1.2	0.7	0.8
Total Debt ($ Bil)	0.3	0.2	0.1	0.2	0.2
Total Cash ($ Bil)	0.2	0.1	0.1	0.0	0.0
Enterprise Value ($ Bil)	1.9	1.5	1.3	0.9	1.0
Valuation Ratios
P/S TTM	2.8	2.3	2.6	1.6	1.7
P/EBIT TTM	21.7	20.8	21.5	46.7	20.4
P/E TTM	37.5	35.7	31.9	125.0	57.4
P/FCF TTM	27.8	49.4	18.6	17.4	19.5
Sector Ratios
P/S TTM (Sector)	1.7	1.5	1.4	1.1	1.6
P/EBIT TTM (Sector)	13.0	11.8	11.2	9.1	12.3
P/E TTM (Sector)	17.3	16.5	15.4	12.1	16.3
P/FCF TTM (Sector)	13.6	13.4	12.1	8.5	14.1

	12/30/25	2024	2023
Share Price CYE	$41.87	$31.96	$32.21
Market Cap CYE ($ Bil)	1.7	1.3	1.2
Total Debt ($ Bil)	0.3	0.2	0.1
Total Cash ($ Bil)	0.2	0.1	0.1
Enterprise Value ($ Bil)	1.9	1.5	1.3
Valuation Ratios
P/S TTM	2.8	2.3	2.6
P/EBIT TTM	21.7	20.8	21.5
P/E TTM	37.5	35.7	31.9
P/FCF TTM	27.8	49.4	18.6
Sector Ratios
P/S TTM (Sector)	1.7	1.5	1.4
P/EBIT TTM (Sector)	13.0	11.8	11.2
P/E TTM (Sector)	17.3	16.5	15.4
P/FCF TTM (Sector)	13.6	13.4	12.1

	CDRE	S&P 500
REVENUE GROWTH	VERY GOOD
Rev LTM ($ Bil)	0.6
Rev Chg Q	42.5%	7.3%
Rev Chg LTM	19.9%	6.1%
Rev Chg 3Y Avg	12.4%	5.5%
PROFITABILITY	FAIR
Op Inc LTM ($ Bil)	0.1
CFO LTM ($ Bil)	0.1
Net Inc LTM ($ Bil)	0.0
Op Mgn LTM	13.7%	18.8%
CFO/Rev LTM	10.7%	20.4%
Net Inc Mgn	7.3%	13.1%
VALUATION	HIGH
P/S	2.8	3.3
P/CFO	25.7	15.8
P/FCF	27.8	20.7
P/E	37.5	23.7
STABILITY	VERY GOOD
Debt/Equity	0.19	0.21
Cash/Assets	0.19	0.07

AI Analysis | Feedback

Metric

Upcoming
3/10/2026	Earnings Release	Rev: - EPS: -

CDRE Stock

Return (1M):

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Here are key points influencing Cadre's (CDRE) stock during the approximate time period from August 31, 2024, to December 30, 2024:

1. Strong Second Quarter 2024 Financial Performance

Cadre Holdings reported robust financial results for the second quarter of 2024 on August 9, 2024, exceeding analyst estimates. The company saw a 19% year-over-year increase in net sales and a 14% increase in net income. Adjusted EBITDA also climbed by 24%, driven by strategic acquisitions and significant demand for its mission-critical safety equipment.

2. Continued High Demand for Safety Equipment

Throughout the third quarter of 2024, Cadre experienced sustained strong demand for its safety products across various markets, including law enforcement, first responders, military, and nuclear. This consistent demand underscored the essential nature of its product portfolio.

Show more

Stock Movement Drivers

Fundamental Drivers

The 15.9% change in CDRE stock from 9/29/2025 to 12/29/2025 was primarily driven by a 10.2% change in the company's Net Income Margin (%).

	9292025	12292025	Change
Stock Price ($)	36.15	41.90	15.91%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	572.61	619.07	8.11%
Net Income Margin (%)	6.65%	7.33%	10.18%
P/E Multiple	38.58	37.55	-2.69%
Shares Outstanding (Mil)	40.66	40.67	-0.01%
Cumulative Contribution			15.91%

LTM = Last Twelve Months as of date shown

Market Drivers

9/29/2025 to 12/29/2025

	Return	Correlation
CDRE	15.9%
Market (SPY)	3.6%	39.7%
Sector (XLI)	2.5%	47.4%

Fundamental Drivers

The 32.2% change in CDRE stock from 6/30/2025 to 12/29/2025 was primarily driven by a 12.2% change in the company's P/E Multiple.

	6302025	12292025	Change
Stock Price ($)	31.69	41.90	32.23%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	559.81	619.07	10.59%
Net Income Margin (%)	6.87%	7.33%	6.72%
P/E Multiple	33.47	37.55	12.17%
Shares Outstanding (Mil)	40.62	40.67	-0.12%
Cumulative Contribution			32.23%

LTM = Last Twelve Months as of date shown

Market Drivers

6/30/2025 to 12/29/2025

	Return	Correlation
CDRE	32.2%
Market (SPY)	11.6%	25.9%
Sector (XLI)	6.8%	42.8%

Fundamental Drivers

The 32.1% change in CDRE stock from 12/29/2024 to 12/29/2025 was primarily driven by a 19.9% change in the company's Total Revenues ($ Mil).

	12292024	12292025	Change
Stock Price ($)	31.71	41.90	32.14%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	516.16	619.07	19.94%
Net Income Margin (%)	6.34%	7.33%	15.56%
P/E Multiple	39.32	37.55	-4.52%
Shares Outstanding (Mil)	40.61	40.67	-0.14%
Cumulative Contribution			32.14%

LTM = Last Twelve Months as of date shown

Market Drivers

12/29/2024 to 12/29/2025

	Return	Correlation
CDRE	32.1%
Market (SPY)	16.6%	36.7%
Sector (XLI)	18.9%	43.9%

Fundamental Drivers

The 115.3% change in CDRE stock from 12/30/2022 to 12/29/2025 was primarily driven by a 814.5% change in the company's Net Income Margin (%).

	12302022	12292025	Change
Stock Price ($)	19.46	41.90	115.32%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	437.73	619.07	41.43%
Net Income Margin (%)	0.80%	7.33%	814.49%
P/E Multiple	206.79	37.55	-81.84%
Shares Outstanding (Mil)	37.29	40.67	-9.06%
Cumulative Contribution			113.56%

LTM = Last Twelve Months as of date shown

Market Drivers

12/30/2023 to 12/29/2025

	Return	Correlation
CDRE	30.1%
Market (SPY)	47.9%	36.9%
Sector (XLI)	41.1%	43.1%

Return vs. Risk

Price Returns Compared

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
CDRE Return	-	67%	-20%	66%	-1%	31%	189%
Peers Return	16%	38%	-12%	21%	26%	16%	151%
S&P 500 Return	16%	27%	-19%	24%	23%	17%	114%
Monthly Win Rates [3]
CDRE Win Rate	-	100%	50%	75%	50%	50%
Peers Win Rate	52%	65%	42%	68%	57%	52%
S&P 500 Win Rate	58%	75%	42%	67%	75%	73%
Max Drawdowns [4]
CDRE Max Drawdown	-	0%	-28%	-8%	-9%	-13%
Peers Max Drawdown	-34%	-5%	-26%	-7%	-9%	-23%
S&P 500 Max Drawdown	-31%	-1%	-25%	-1%	-2%	-15%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: HPQ, HPE, IBM, CSCO, AAPL.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/29/2025 (YTD)

How Low Can It Go

Unique Key	Event	CDRE	S&P 500
2022 Inflation Shock	2022 Inflation Shock
2022 Inflation Shock% Loss	% Loss	-39.7%	-25.4%
2022 Inflation Shock% Gain to Breakeven	% Gain to Breakeven	65.8%	34.1%
2022 Inflation ShockTime to Breakeven	Time to Breakeven	231 days	464 days

Compare to HPQ, HPE, IBM, CSCO, AAPL

In The Past

Cadre's stock fell -39.7% during the 2022 Inflation Shock from a high on 11/1/2022. A -39.7% loss requires a 65.8% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Cadre (CDRE)

Business Description Analogies Products Customers Suppliers Management Key Risks Emerging Threats Market Size Revenue Drivers Capital Allocation

Cadre Holdings, Inc. manufactures and distributes safety and survivability equipment that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It primarily provides body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brands; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective and law enforcement equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, and various foreign government agencies. The company was founded in 1964 and is headquartered in Jacksonville, Florida.

AI Analysis | Feedback

Here are 1-3 brief analogies to describe Cadre:

A "Lockheed Martin for the individual," specializing in body armor and tactical gear for law enforcement and military personnel.
A "Stryker for professional safety," providing critical protective gear like body armor and EOD equipment to first responders and military.

AI Analysis | Feedback

Body Armor: Provides ballistic vests and plates designed for personal protection for law enforcement and military personnel.
Duty Gear and Holsters: Manufactures a wide range of essential equipment, including holsters, belts, and pouches, for law enforcement and military use.
Less Lethal Products: Offers non-lethal tools and munitions used for crowd control and de-escalation in law enforcement and security applications.
Explosive Ordnance Disposal (EOD) Equipment: Supplies specialized suits, helmets, and robotic systems for bomb disposal and hazardous device mitigation.

AI Analysis | Feedback

Cadre (CDRE) Major Customers

Cadre (CDRE) operates as a technology-driven real estate investment platform that provides individuals and institutions access to high-quality commercial real estate investments. Its "customers" are primarily the investors who utilize its platform to invest in these opportunities rather than direct buyers of real estate or tenants.

Cadre serves the following categories of investors:

High-Net-Worth Individuals (HNWIs) / Accredited Investors: These are individuals who meet specific financial criteria, allowing them to participate in private investment offerings through Cadre's platform.
Family Offices: These are private entities or organizations established to manage the wealth and investments for affluent families, often investing substantial capital into real estate opportunities facilitated by Cadre.
Institutional Investors: This broad category includes various large organizations such as endowments, foundations, pension funds, and other financial institutions that seek to allocate capital into commercial real estate via Cadre's platform.

AI Analysis | Feedback

3M Company (NYSE: MMM)
Honeywell International Inc. (NASDAQ: HON)
MSA Safety Incorporated (NYSE: MSA)
DuPont de Nemours, Inc. (NYSE: DD)
Kimberly-Clark Corporation (NYSE: KMB)

AI Analysis | Feedback

Warren B. Kanders, Chief Executive Officer & Chairman of the Board
Warren B. Kanders has served as Cadre's Chief Executive Officer since April 2012. He has also been a director and Executive Chairman of Clarus Corporation, a NASDAQ-listed company, since 2002. From January 1996 until its sale to BAE Systems plc on July 31, 2007, Mr. Kanders was the Chairman of the Board of Directors and, from April 2003, the Chief Executive Officer of Armor Holdings, Inc., a manufacturer and supplier of military vehicles and safety products.
Blaine Browers, Chief Financial Officer
Blaine Browers was appointed Chief Financial Officer in May 2018. Prior to joining Cadre, Mr. Browers held various roles of increasing responsibility at IDEX Corporation from September 2010 to April 2018, including Group Vice President Finance & IT. He also held positions within General Electric Co. before his time at IDEX.
Brad Williams, President
Brad Williams was appointed Chief Operating Officer in March 2017 and promoted to President in 2019. Before joining Cadre, Mr. Williams served in various roles at IDEX Corporation from June 2010 to March 2017, including President, Material Processing Technologies Group. He also held various positions within Danaher Corporation and Ingersoll-Rand Company.

AI Analysis | Feedback

The key risks for Cadre Holdings, Inc. (symbol: CDRE) include:

Regulatory Compliance and Product Liability: Cadre operates in highly regulated markets such as law enforcement, military, and nuclear sectors, subjecting it to extensive government regulations. Non-compliance could significantly restrict operations and result in substantial penalties. Additionally, the inherently risky nature of products like body armor and explosive ordnance disposal equipment exposes the company to significant risks related to product liability and warranty claims.
Fluctuating Government Budgets: As a primary supplier to government agencies, Cadre's demand for products can vary substantially due to fluctuations in government budgets.
Intense Competition: Cadre faces an intense competitive landscape, where technological advancements and new product introductions pose a threat if the company cannot adapt quickly.

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

Cadre (CDRE) is anticipated to drive future revenue growth over the next 2-3 years through several key strategies and market dynamics:

Strategic Acquisitions: Cadre's strategy of disciplined mergers and acquisitions is a significant growth driver. The recent acquisition of TYR Tactical is expected to bolster capabilities, enhance the company's competitive edge, and unlock new growth opportunities, particularly in high-value end markets with military customers in Northern Europe. This strategy is intended to expand Cadre's product offerings and market reach.
Innovative Product Launches and Portfolio Expansion: The company attributes growth to innovative product launches, such as the HyperX tactical carrier system, and continued product innovation. Strategic acquisitions also enhance Cadre's portfolio of mission-critical products.
Increased Demand in Key Public Safety and Defense Markets: Cadre anticipates continued growth driven by increasing demand in public safety, law enforcement, first responder, military, and nuclear markets. This is fueled by rising global safety threats and sustained government investment in protection equipment.
Capitalizing on Organic Backlog and Previously Delayed Opportunities: The company has reported a sequential increase in its organic backlog, reflecting progress in converting previously delayed opportunities into revenue. While some large order opportunities were deferred to 2026, realizing these can contribute to future growth.
International Market Expansion: The acquisition of TYR Tactical is specifically mentioned to open new growth avenues, especially within military customer segments in Northern Europe, indicating a focus on expanding Cadre's international presence.

AI Analysis | Feedback

Share Issuance

Cadre Holdings completed its initial public offering (IPO) in November 2021.
The company's shares outstanding increased by 3.36% year-over-year.
Shares are issued upon the vesting of restricted stock awards.

Inbound Investments

Cadre Holdings successfully completed its IPO in November 2021.

Outbound Investments

On October 29, 2025, Cadre Holdings announced the acquisition of TYR Tactical, LLC.
The total consideration for the TYR Tactical acquisition is $175 million, comprising $150 million in cash and $25 million in stock, with a potential additional contingent earn-out of up to $25 million.

Capital Expenditures

Expected capital expenditures for the full year 2025 are projected to be in the range of $7 million to $8 million.
Capital expenditures totaled $5.8 million for the full year 2024.
Capital expenditures were $7.0 million for the full year 2023.

Better Bets than Cadre (CDRE)

INDUSTRY: Aerospace & Defense

Higher Rev Chg 3Y Avg | Lower P/S (Values for CDRE: 12.4% | 2.8x)

PSN (17.9% | 1.0x)

Parsons

AIR (16.4% | 1.1x)

AAR

ATRO (19.5% | 2.3x)

Astronics

VVX (26.7% | 0.4x)

V2X

NPK (16.4% | 1.6x)

National Presto Industries

Higher Rev Chg 3Y Avg | Lower P/Op Inc (Values for CDRE: 12.4% | 20.1x)

TDG (17.7% | 18.3x)

TransDigm

PSN (17.9% | 16.3x)

Parsons

AIR (16.4% | 15.0x)

AAR

VVX (26.7% | 9.1x)

V2X

NPK (16.4% | 16.2x)

National Presto Industries

Higher Rev Chg LTM (Value for CDRE: 19.9%)

AVAV (79.9%)

AeroVironment

RKLB (52.4%)

Rocket Lab

AXON (32.0%)

Axon Enterprise

KRMN (29.4%)

Karman

LOAR (25.4%)

Loar

Higher Rev Chg 3Y Avg (Value for CDRE: 12.4%)

AXON (33.7%)

Axon Enterprise

HEI (26.9%)

Heico

TDG (17.7%)

TransDigm

GE (15.7%)

GE Aerospace

HWM (13.5%)

Howmet Aerospace

Higher Op Mgn LTM (Value for CDRE: 13.7%)

TDG (47.4%)

TransDigm

HWM (24.0%)

Howmet Aerospace

HEI (22.7%)

Heico

GE (20.5%)

GE Aerospace

CW (18.3%)

Curtiss-Wright

Higher CFO/Rev LTM (Value for CDRE: 10.7%)

TDG (23.1%)

TransDigm

HWM (18.4%)

Howmet Aerospace

GE (17.2%)

GE Aerospace

LHX (11.7%)

L3Harris Technologies

GD (11.1%)

General Dynamics

Higher FCF/Rev LTM (Value for CDRE: 9.9%)

TDG (20.6%)

TransDigm

HEI (19.2%)

Heico

GE (14.7%)

GE Aerospace

HWM (13.2%)

Howmet Aerospace

LHX (10.1%)

L3Harris Technologies

Higher Total Yield (Value for CDRE: 3.6%)

TDG (15.3%)

TransDigm

GD (6.3%)

General Dynamics

LMT (5.8%)

Lockheed Martin

NOC (5.6%)

Northrop Grumman

RTX (4.1%)

RTX

SECTOR: Industrials

Higher Rev Chg 3Y Avg | Lower P/S (Values for CDRE: 12.4% | 2.8x)

PWR (17.9% | 2.4x)

Quanta Services

UAL (13.2% | 0.6x)

United Airlines

EME (14.7% | 1.7x)

EMCOR

MTZ (17.8% | 1.3x)

MasTec

XPO (38.4% | 2.0x)

XPO

Higher Rev Chg 3Y Avg | Lower P/Op Inc (Values for CDRE: 12.4% | 20.1x)

TDG (17.7% | 18.3x)

TransDigm

CP (22.2% | 12.2x)

Canadian Pacific Kansas City

URI (13.2% | 13.1x)

United Rentals

UAL (13.2% | 7.0x)

United Airlines

EME (14.7% | 18.3x)

EMCOR

Higher Rev Chg LTM (Value for CDRE: 19.9%)

RKLB (52.4%)

Rocket Lab

BE (44.5%)

Bloom Energy

AXON (32.0%)

Axon Enterprise

VRT (28.8%)

Vertiv

FIX (27.7%)

Comfort Systems USA

Higher Rev Chg 3Y Avg (Value for CDRE: 12.4%)

CP (22.2%)

Canadian Pacific Kansas City

UBER (19.6%)

Uber Technologies

TDG (17.7%)

TransDigm

GE (15.7%)

GE Aerospace

HWM (13.5%)

Howmet Aerospace

Higher Op Mgn LTM (Value for CDRE: 13.7%)

UNP (40.6%)

Union Pacific

GE (20.5%)

GE Aerospace

HON (18.9%)

Honeywell International

DE (18.8%)

Deere

CAT (17.7%)

Caterpillar

Higher CFO/Rev LTM (Value for CDRE: 10.7%)

UNP (39.6%)

Union Pacific

UBER (18.1%)

Uber Technologies

CAT (17.8%)

Caterpillar

GE (17.2%)

GE Aerospace

DE (16.7%)

Deere

Higher FCF/Rev LTM (Value for CDRE: 9.9%)

UNP (24.5%)

Union Pacific

UBER (17.5%)

Uber Technologies

HON (15.2%)

Honeywell International

GE (14.7%)

GE Aerospace

CAT (11.7%)

Caterpillar

Higher Total Yield (Value for CDRE: 3.6%)

UBER (9.8%)

Uber Technologies

UNP (7.4%)

Union Pacific

DE (5.3%)

Deere

CAT (4.4%)

Caterpillar

RTX (4.1%)

RTX

All Other Sectors

Higher Rev Chg 3Y Avg | Lower P/S (Values for CDRE: 12.4% | 2.8x)

BRK-B (19.8% | 2.7x)

Berkshire Hathaway

PGR (20.6% | 1.6x)

Progressive

MCK (12.6% | 0.3x)

McKesson

CI (13.6% | 0.3x)

Cigna

WBD (17.2% | 1.9x)

Warner Bros. Discovery

Higher Rev Chg 3Y Avg | Lower P/Op Inc (Values for CDRE: 12.4% | 20.1x)

BKNG (17.8% | 19.6x)

Booking

NEM (23.9% | 11.7x)

Newmont

MCK (12.6% | 18.8x)

McKesson

APO (89.3% | 10.7x)

Apollo Asset Management

AEM (26.0% | 16.5x)

Agnico Eagle Mines

Higher Rev Chg LTM (Value for CDRE: 19.9%)

NVDA (65.2%)

NVIDIA

PLTR (47.2%)

Palantir Technologies

LLY (36.8%)

Eli Lilly

AVGO (23.9%)

Broadcom

META (21.3%)

Meta Platforms

Higher Rev Chg 3Y Avg (Value for CDRE: 12.4%)

NVDA (91.6%)

NVIDIA

AVGO (25.2%)

Broadcom

BRK-B (19.8%)

Berkshire Hathaway

META (17.3%)

Meta Platforms

MSFT (13.2%)

Microsoft

Higher Op Mgn LTM (Value for CDRE: 13.7%)

NVDA (58.8%)

NVIDIA

MSFT (46.3%)

Microsoft

META (43.2%)

Meta Platforms

GOOGL (32.2%)

Alphabet

AAPL (31.9%)

Apple

Higher CFO/Rev LTM (Value for CDRE: 10.7%)

MSFT (50.0%)

Microsoft

NVDA (44.4%)

NVIDIA

GOOGL (39.3%)

Alphabet

AAPL (26.6%)

Apple

AMZN (18.1%)

Amazon.com

Higher FCF/Rev LTM (Value for CDRE: 9.9%)

NVDA (41.3%)

NVIDIA

MSFT (26.6%)

Microsoft

META (23.7%)

Meta Platforms

AAPL (23.5%)

Apple

GOOGL (19.1%)

Alphabet

Higher Total Yield (Value for CDRE: 3.6%)

JPM (6.5%)

JPMorgan Chase

BRK-B (6.2%)

Berkshire Hathaway

META (3.8%)

Meta Platforms

ORCL (3.7%)

Oracle

MSFT (3.6%)

Microsoft

		Best Bets In Industrials Sector
	CDRE	GATX	VRSK	PAYX	ADT	AGX	PCTY	TDG	FTV	VRRM	CSW
What You Pay
P/E	37.5	19.8	34.0	25.7	10.3	37.0	37.9	36.9	30.8	71.0	35.7
P/EBIT	21.7	9.5	23.2	17.7	5.2	37.1	27.2	18.2	15.0	21.0	27.6
What You Get
Rev Chg Q	42.5%	8.4%	5.9%	18.3%	4.4%	-2.3%	12.5%	11.5%	2.3%	16.1%	21.5%
Rev Chg LTM	19.9%	10.7%	7.3%	12.4%	6.3%	13.5%	13.3%	11.2%	27.9%	8.5%	14.9%
Rev Chg 3Y Avg	12.4%	10.3%	13.4%	7.9%	3.4%	26.9%	21.4%	17.7%	9.4%	9.1%	11.3%
FCF/Rev 3Y Avg	9.1%	39.2%	33.2%	32.6%	24.7%	24.5%	21.5%	21.0%	20.1%	19.0%	18.9%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 16%, alpha of 4.2%, and sharpe of 0.76

Latest Trefis Analyses

	Title	Topic
0	DASHBOARDS
1	Cadre Earnings Notes
2	How Low Can Cadre Stock Really Go?	Return
3	Why Cadre Stock Moved: CDRE Stock Has Gained 114% Since 2022 Fiscal End, Primarily Due To Favorable Change In Price To Sales Multiple (P/S)
4	CDRE Dip Buy Analysis
5	Should You Buy Cadre Stock?	Buy or Fear
6	Cadre (CDRE) Valuation Ratios Comparison	Financials
7	Cadre (CDRE) Operating Cash Flow Comparison	Financials
8	Cadre (CDRE) Net Income Comparison	Financials
9	Cadre (CDRE) Operating Income Comparison	Financials
10	Cadre (CDRE) Revenue Comparison	Financials

	Title
0	ARTICLES

Trade Ideas

Select ideas related to CDRE. For more, see Trefis Trade Ideas.

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
CNM_11212025_Dip_Buyer_FCFYield	11212025	CNM	Core & Main	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	18.3%	18.3%	-1.6%
VRRM_11212025_Dip_Buyer_FCFYield	11212025	VRRM	Verra Mobility	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	5.5%	5.5%	-1.2%
LII_11212025_Dip_Buyer_ValueBuy	11212025	LII	Lennox International	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	7.1%	7.1%	0.0%
ADP_11212025_Monopoly_xInd_xCD_Getting_Cheaper	11212025	ADP	Automatic Data Processing	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	2.9%	2.9%	-1.2%
CW_11212025_Quality_Momentum_RoomToRun_10%	11212025	CW	Curtiss-Wright	Quality	Q \| Momentum \| UpsideQuality Stocks with Momentum and Upside Buying quality stocks with strong momentum but still having room to run	5.7%	5.7%	-0.4%

Recent Active Movers

Top Gainers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
PRAX	Praxis Precision Medicines	6.7	13.2%	295.8%
HPK	HighPeak Energy	0.6	9.8%	-67.5%
DBRG	DigitalBridge	2.7	9.6%	35.7%
METCB	Ramaco Resources	0.7	8.8%	49.5%
AQST	Aquestive Therapeutics	0.7	8.0%	81.7%
PGEN	Precigen	1.3	7.0%	297.3%
BW	Babcock & Wilcox Enterprises	0.5	5.5%	237.8%
OMER	Omeros	1.0	5.5%	67.7%
SCHL	Scholastic	0.8	4.8%	49.7%
EVMN	Evommune	0.5	4.6%	-11.0%

Top Losers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
RARE	Ultragenyx Pharmaceutical	2.0	-42.3%	-53.1%
USAS	Americas Gold And Silver	1.4	-12.5%	475.7%
UAMY	United States Antimony	0.7	-10.1%	216.9%
UP	Wheels Up Experience	0.4	-9.8%	-63.3%
ITRG	Integra Resources	0.7	-9.6%	366.7%
BRBR	BellRing Brands	3.5	-9.4%	-63.7%
RZLT	Rezolute	0.3	-9.0%	-50.4%
SGML	Sigma Lithium	1.5	-8.8%	17.9%
IMSR	Terrestrial Energy	0.6	-8.5%	-59.4%
ZBIO	Zenas BioPharma	1.6	-8.1%	376.8%

Top Gainers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
OMER	Omeros	1.0	72.6%	67.7%
DVAX	Dynavax Technologies	1.8	41.5%	20.4%
RZLT	Rezolute	0.3	37.3%	-50.4%
ADEA	Adeia	1.9	35.6%	25.7%
METC	Ramaco Resources	1.1	25.1%	80.3%
AAOI	Applied Optoelectronics	2.3	17.3%	-0.3%
BNTC	Benitec Biopharma	0.6	17.3%	6.8%
UAMY	United States Antimony	0.7	16.4%	216.9%
DBRG	DigitalBridge	2.7	15.7%	35.7%
METCB	Ramaco Resources	0.7	15.5%	49.5%

Top Losers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
TPL	Texas Pacific Land	6.8	-67.2%	-19.6%
RARE	Ultragenyx Pharmaceutical	2.0	-41.1%	-53.1%
LAB	Standard BioTools	0.5	-21.5%	-26.9%
NNE	Nano Nuclear Energy	1.0	-20.0%	6.1%
TMC	TMC The Metals	2.3	-19.9%	464.3%
IMSR	Terrestrial Energy	0.6	-18.9%	-59.4%
DJT	Trump Media & Technology	3.7	-18.2%	-61.4%
TLRY	Tilray Brands	9.8	-17.0%	-30.4%
EVEX	Eve	1.3	-16.5%	-26.3%
TDUP	ThredUp	0.8	-16.2%	351.1%

Top Gainers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
TLRY	Tilray Brands	9.8	799.0%	-30.4%
HPP	Hudson Pacific Properties	4.7	428.6%	-51.2%
WVE	WAVE Life Sciences	2.9	132.9%	44.4%
OMER	Omeros	1.0	72.1%	67.7%
PL	Planet Labs PBC	6.0	69.5%	391.8%
LUNR	Intuitive Machines	1.8	69.0%	-13.5%
RKLB	Rocket Lab	36.1	67.2%	175.3%
TE	T1 Energy	1.0	67.2%	372.1%
PRAX	Praxis Precision Medicines	6.7	61.5%	295.8%
DBRG	DigitalBridge	2.7	60.3%	35.7%

Top Losers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
RZLT	Rezolute	0.3	-74.6%	-50.4%
JANX	Janux Therapeutics	0.9	-59.4%	-73.7%
FRMI	Fermi	5.3	-52.4%	-76.9%
LENZ	LENZ Therapeutics	0.5	-46.2%	-42.8%
RARE	Ultragenyx Pharmaceutical	2.0	-41.6%	-53.1%
NKTR	Nektar Therapeutics	0.6	-35.0%	206.3%
GOGO	Gogo	0.6	-33.9%	-42.2%
SYM	Symbotic	6.5	-31.5%	152.3%
IMSR	Terrestrial Energy	0.6	-30.9%	-59.4%
ORIC	ORIC Pharmaceuticals	0.6	-30.2%	2.2%

Peer Comparisons for Cadre

Peers to compare with:

Financials

	CDRE	HPQ	HPE	IBM	CSCO	AAPL	Median
Name	Cadre	HP	Hewlett .	Internat.	Cisco Sy.	Apple
Mkt Price	41.90	22.73	24.33	305.74	77.79	273.76	59.84
Mkt Cap	1.7	21.4	32.4	285.5	307.7	4,079.8	159.0
Rev LTM	619	55,295	34,296	65,402	57,696	408,625	56,496
Op Inc LTM	85	3,624	1,644	11,544	12,991	130,214	7,584
FCF LTM	61	2,800	627	11,854	12,733	96,184	7,327
FCF 3Y Avg	49	2,978	1,400	11,753	13,879	100,503	7,366
CFO LTM	66	3,697	2,919	13,483	13,744	108,565	8,590
CFO 3Y Avg	55	3,672	3,896	13,498	14,736	111,559	8,697

Growth & Margins

	CDRE	HPQ	HPE	IBM	CSCO	AAPL	Median
Name	Cadre	HP	Hewlett .	Internat.	Cisco Sy.	Apple
Rev Chg LTM	19.9%	3.2%	13.8%	4.5%	8.9%	6.0%	7.4%
Rev Chg 3Y Avg	12.4%	-3.9%	6.5%	2.6%	3.7%	1.8%	3.2%
Rev Chg Q	42.5%	4.2%	14.4%	9.1%	7.5%	9.6%	9.4%
QoQ Delta Rev Chg LTM	8.1%	1.1%	3.7%	2.1%	1.8%	2.1%	2.1%
Op Mgn LTM	13.7%	6.6%	4.8%	17.7%	22.5%	31.9%	15.7%
Op Mgn 3Y Avg	12.2%	7.4%	7.2%	16.4%	24.2%	30.8%	14.3%
QoQ Delta Op Mgn LTM	1.5%	-0.2%	-1.4%	0.6%	0.4%	0.1%	0.2%
CFO/Rev LTM	10.7%	6.7%	8.5%	20.6%	23.8%	26.6%	15.7%
CFO/Rev 3Y Avg	10.2%	6.8%	12.7%	21.4%	26.1%	28.4%	17.1%
FCF/Rev LTM	9.9%	5.1%	1.8%	18.1%	22.1%	23.5%	14.0%
FCF/Rev 3Y Avg	9.1%	5.5%	4.6%	18.6%	24.6%	25.6%	13.9%

Valuation

	CDRE	HPQ	HPE	IBM	CSCO	AAPL	Median
Name	Cadre	HP	Hewlett .	Internat.	Cisco Sy.	Apple
Mkt Cap	1.7	21.4	32.4	285.5	307.7	4,079.8	159.0
P/S	2.8	0.4	0.9	4.4	5.3	10.0	3.6
P/EBIT	21.7	6.6	19.7	25.1	22.4	31.3	22.1
P/E	37.5	8.4	569.0	36.1	29.8	41.1	36.8
P/CFO	25.8	5.8	11.1	21.2	22.4	37.6	21.8
Total Yield	3.6%	14.4%	2.3%	5.0%	5.5%	2.8%	4.3%
Dividend Yield	0.9%	2.5%	2.1%	2.2%	2.1%	0.4%	2.1%
FCF Yield 3Y Avg	3.9%	10.6%	5.5%	6.4%	6.0%	3.1%	5.7%
D/E	0.2	0.5	0.7	0.2	0.1	0.0	0.2
Net D/E	0.1	0.3	0.6	0.2	0.0	0.0	0.1

Returns

	CDRE	HPQ	HPE	IBM	CSCO	AAPL	Median
Name	Cadre	HP	Hewlett .	Internat.	Cisco Sy.	Apple
1M Rtn	-1.8%	-5.8%	11.9%	-0.9%	1.1%	-1.8%	-1.4%
3M Rtn	15.9%	-14.5%	1.4%	9.9%	15.6%	7.7%	8.8%
6M Rtn	32.2%	-5.0%	20.3%	5.0%	13.5%	33.7%	16.9%
12M Rtn	32.1%	-28.7%	15.4%	40.8%	33.9%	7.6%	23.8%
3Y Rtn	115.3%	-5.3%	65.8%	142.1%	78.3%	113.9%	96.1%
1M Excs Rtn	-4.1%	-5.5%	12.3%	-0.5%	0.9%	-2.7%	-1.6%
3M Excs Rtn	12.2%	-18.1%	-2.3%	6.2%	11.9%	4.0%	5.1%
6M Excs Rtn	20.9%	-16.3%	9.0%	-6.3%	2.2%	22.4%	5.6%
12M Excs Rtn	16.8%	-43.3%	-0.2%	25.4%	19.0%	-7.8%	8.3%
3Y Excs Rtn	28.5%	-82.8%	-10.4%	61.9%	0.1%	27.1%	13.6%

FDIC Bank Data

Bank Capital

null

Bank Deposits

null

Bank Assets

null

Bank Loans

null

FDA Approved Drugs Data

Expand for Morenull

Financials

Annual
Quarterly

$ Mil \| FY: 12/31	LTM	2024	2023	2022	2021	2020	2019
Period End	9/30/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Filing Date	11/4/2025	3/11/2025	3/12/2024	3/15/2023	3/11/2022	11/5/2021	11/5/2021
Key Financials
Total Revenue	619	568	483	458	427	405	421
EBITDA	96	78	73	31	49	67	43
Operating Income	85	73	59	21	55	56	28
Net Income	45	36	39	6	13	38	-2
EPS	1.12	0.90	1.03	0.16	0.44	1.15	-0.06
Growth Rates
Total Revenue Growth	19.9%	17.6%	5.4%	7.1%	5.6%	-3.8%	-
EBITDA Growth	46.0%	7.2%	134.4%	-36.7%	-26.4%	55.0%	-
Operating Income Growth	55.2%	23.9%	178.6%	-61.8%	-0.9%	96.6%	-
Net Income Growth	38.6%	-6.5%	563.9%	-54.0%	-67.1%	2094.5%	-
Margins
EBITDA Margin	15.6%	13.8%	15.2%	6.8%	11.5%	16.6%	10.3%
Operating Income Margin	13.7%	12.8%	12.2%	4.6%	12.9%	13.7%	6.7%
Net Income Margin	7.3%	6.4%	8.0%	1.3%	3.0%	9.5%	-0.5%
Cash & Debt
Total Cash	151	125	88	45	34	3	3
Total Debt	327	239	147	158	160	213	275
Net Debt / (Cash)	176	114	59	113	126	210	272
Cash Flows
Net Cash from Operations	66	32	73	46	40	45	7
Free Cash from Operations	61	26	66	42	37	41	4
Returns to Shareholders
Dividends	15	14	12	12	13	-0	-0
Share Repurchases	-0	-0	-0	-0	-0	-0	-0

$ Mil \| FY: 12/31	2025Q3	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4
Period End	9/30/2025	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022
Filing Date	11/4/2025	8/5/2025	5/6/2025	3/11/2025	11/6/2024	8/9/2024	5/8/2024	3/12/2024	11/8/2023	8/8/2023	5/9/2023	3/15/2023
Key Financials Quarterly
Total Revenue	156	157	130	176	109	144	138	125	125	121	112	124
Ebitda	23	25	19	29	11	24	14	17	21	20	16	19
Operating Income	21	18	14	32	6	20	15	14	17	17	11	14
Net Income	11	12	9	13	4	13	7	10	11	11	7	7
EPS	0.27	0.30	0.23	0.32	0.09	0.31	0.18	0.26	0.29	0.29	0.19	0.18
Key Financials TTM
Total Revenue TTM	619	573	560	568	516	532	509	483	482	468	465	458
Ebitda TTM	96	84	83	78	66	76	72	73	75	67	58	31
Operating Income TTM	85	70	72	73	55	66	63	59	59	53	46	21
Net Income TTM	45	38	38	36	33	40	39	39	36	30	23	6
Growth Rates Quarterly
Total Revenue Growth	42.5%	8.9%	-5.6%	41.3%	-12.6%	19.2%	23.4%	0.8%	12.2%	2.4%	7.0%	19.4%
EBITDA Growth	116.4%	5.1%	29.1%	75.0%	-47.8%	20.0%	-8.6%	-11.5%	65.9%	79.7%	242.2%	49.3%
Operating Income Growth	251.6%	-9.8%	-5.4%	131.4%	-65.4%	20.5%	34.3%	0.3%	44.4%	77.1%	180.8%	21.7%
Net Income Growth	199.3%	-2.8%	33.5%	35.3%	-66.9%	14.3%	-1.1%	45.4%	123.7%	147.3%	168.9%	53.9%
Margins Quarterly
EBITDA Margin	14.9%	16.2%	14.4%	16.5%	9.8%	16.8%	10.5%	13.3%	16.5%	16.7%	14.2%	15.1%
Operating Income Margin	13.4%	11.5%	11.0%	18.1%	5.4%	13.8%	10.9%	11.0%	13.7%	13.7%	10.0%	11.1%
Net Income Margin	7.0%	7.8%	7.1%	7.4%	3.3%	8.7%	5.0%	7.7%	8.8%	9.1%	6.3%	5.3%
Cash & Debt
Total Cash	151	137	133	125	93	106	87	88	69	56	48	45
Total Debt	327	331	231	239	220	217	222	147	147	146	150	158
Net Debt / (Cash)	176	193	98	114	127	112	135	59	78	90	102	113
Cash Flows Quarterly
FCF from Operations	22	3	17	24	-5	11	2	27	18	16	13	17
Cash Flows TTM
FCF from Operations TTM	66	38	47	32	35	58	63	73	63	50	50	46
Returns to Shareholders Quarterly
Dividends	4	4	4	4	4	4	3	3	3	3	3	3
Share Repurchases	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	12.6%	10.1%	10.3%	17.3%	4.0%	13.8%	11.2%	15.6%	17.0%	15.9%	10.2%	8.9%
Return on Invested Capital (ROIC) TTM
ROIC TTM	11.7%	9.2%	11.8%	11.6%	9.5%	11.8%	11.1%	15.7%	13.5%	11.7%	9.6%	4.1%

Segment Financials

Revenue by Segment

$ Mil	2024	2023	2022
Product	411	385	362
Distribution	102	97	90
Reconciling Items	-31	-25	-25
Total	483	458	427

Price Behavior

Price Behavior

Market Price	$41.90
Market Cap ($ Bil)	1.7
First Trading Date	11/04/2021
Distance from 52W High	-7.1%
	50 Days	200 Days
DMA Price	$42.32	$34.99
DMA Trend	up	up
Distance from DMA	-1.0%	19.8%
	3M	1YR
Volatility	31.0%	43.4%
Downside Capture	95.47	93.70
Upside Capture	150.98	107.03
Correlation (SPY)	39.6%	36.5%

CDRE Betas & Captures as of 11/30/2025

	1M	2M	3M	6M	1Y	3Y
Beta	1.40	0.94	0.97	1.02	0.75	0.78
Up Beta	1.24	0.86	1.43	1.52	0.67	0.76
Down Beta	-0.47	0.82	0.81	1.00	0.64	0.88
Up Capture	188%	168%	191%	110%	97%	50%
Bmk +ve Days	12	25	38	73	141	426
Stock +ve Days	8	21	34	69	130	403
Down Capture	162%	59%	21%	65%	88%	90%
Bmk -ve Days	7	16	24	52	107	323
Stock -ve Days	10	19	27	55	116	341

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Based On 1-Year Data

null

Based On 5-Year Data

null

Based On 10-Year Data

null

Short Interest

Short Interest: As Of Date	12152025
Short Interest: Shares Quantity	2,348,239
Short Interest: % Change Since 11302025	11.2%
Average Daily Volume	259,621
Days-to-Cover Short Interest	9.04
Basic Shares Quantity	40,666,861
Short % of Basic Shares	5.8%

Returns Analyses

	Title
0	How Low Can Cadre Stock Really Go?

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
11/4/2025	6.1%	2.6%	0.8%
8/5/2025	-15.9%	-13.3%	-7.0%
3/11/2025	5.1%	-3.5%	-9.0%
11/6/2024	-8.5%	-10.3%	-4.4%
8/9/2024	0.4%	2.5%	-0.2%
3/5/2024	0.3%	6.0%	-2.9%
11/8/2023	7.9%	13.2%	13.3%
8/8/2023	9.6%	7.0%	11.1%
...
SUMMARY STATS
# Positive	8	8	7
# Negative	5	5	6
Median Positive	4.9%	4.3%	11.1%
Median Negative	-5.0%	-7.2%	-5.7%
Max Positive	9.6%	13.2%	23.6%
Max Negative	-15.9%	-13.3%	-22.5%

	Forward Returns
11/4/2025	6.1%	2.6%	0.8%
8/5/2025	-15.9%	-13.3%	-7.0%
3/11/2025	5.1%	-3.5%	-9.0%
11/6/2024	-8.5%	-10.3%	-4.4%
8/9/2024	0.4%	2.5%	-0.2%
3/5/2024	0.3%	6.0%	-2.9%
11/8/2023	7.9%	13.2%	13.3%
8/8/2023	9.6%	7.0%	11.1%
3/15/2023	-3.7%	-5.2%	13.6%
11/10/2022	4.6%	-7.2%	-22.5%
8/11/2022	-5.0%	0.5%	1.0%
3/10/2022	-2.7%	10.4%	3.9%
12/2/2021	0.0%	1.8%	23.6%
SUMMARY STATS
# Positive	8	8	7
# Negative	5	5	6
Median Positive	4.9%	4.3%	11.1%
Median Negative	-5.0%	-7.2%	-5.7%
Max Positive	9.6%	13.2%	23.6%
Max Negative	-15.9%	-13.3%	-22.5%

SEC Filings

Expand for More

Report Date	Filing Date	Filing
09/30/2025	11/04/2025	10-Q (09/30/2025)
06/30/2025	08/05/2025	10-Q (06/30/2025)
03/31/2025	05/06/2025	10-Q (03/31/2025)
12/31/2024	03/11/2025	10-K (12/31/2024)
09/30/2024	11/06/2024	10-Q (09/30/2024)
06/30/2024	08/09/2024	10-Q (06/30/2024)
03/31/2024	05/08/2024	10-Q (03/31/2024)
12/31/2023	03/12/2024	10-K (12/31/2023)
09/30/2023	11/08/2023	10-Q (09/30/2023)
06/30/2023	08/08/2023	10-Q (06/30/2023)
03/31/2023	05/09/2023	10-Q (03/31/2023)
12/31/2022	03/15/2023	10-K (12/31/2022)
09/30/2022	11/10/2022	10-Q (09/30/2022)
06/30/2022	08/11/2022	10-Q (06/30/2022)
03/31/2022	05/16/2022	10-Q (03/31/2022)
12/31/2021	03/11/2022	10-K (12/31/2021)

Insider Activity

Expand for Morenull

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Cadre (CDRE)

Market Price (12/30/2025): $41.87 | Market Cap: $1.7 BilSector: Industrials | Industry: Aerospace & Defense

Cadre (CDRE)

Market Price (12/30/2025): $41.87Market Cap: $1.7 BilSector: IndustrialsIndustry: Aerospace & Defense

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

Valuation, Metrics & Events

CDRE Stock

Why The Stock Moved

Qualitative Assessment

Stock Movement Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Return vs. Risk

Price Returns Compared

How Low Can It Go

In The Past

Preserve Wealth

Asset Allocation

About Cadre (CDRE)

Cadre (CDRE) Major Customers

Interactive Breakdown

Better Bets than Cadre (CDRE)

INDUSTRY: Aerospace & Defense

Higher Rev Chg 3Y Avg | Lower P/S (Values for CDRE: 12.4% | 2.8x)

Higher Rev Chg 3Y Avg | Lower P/Op Inc (Values for CDRE: 12.4% | 20.1x)

Higher Rev Chg LTM (Value for CDRE: 19.9%)

Higher Rev Chg 3Y Avg (Value for CDRE: 12.4%)

Higher Op Mgn LTM (Value for CDRE: 13.7%)

Higher CFO/Rev LTM (Value for CDRE: 10.7%)

Higher FCF/Rev LTM (Value for CDRE: 9.9%)

Higher Total Yield (Value for CDRE: 3.6%)

SECTOR: Industrials

Higher Rev Chg 3Y Avg | Lower P/S (Values for CDRE: 12.4% | 2.8x)

Higher Rev Chg 3Y Avg | Lower P/Op Inc (Values for CDRE: 12.4% | 20.1x)

Higher Rev Chg LTM (Value for CDRE: 19.9%)

Higher Rev Chg 3Y Avg (Value for CDRE: 12.4%)

Higher Op Mgn LTM (Value for CDRE: 13.7%)

Higher CFO/Rev LTM (Value for CDRE: 10.7%)

Higher FCF/Rev LTM (Value for CDRE: 9.9%)

Higher Total Yield (Value for CDRE: 3.6%)

All Other Sectors

Higher Rev Chg 3Y Avg | Lower P/S (Values for CDRE: 12.4% | 2.8x)

Higher Rev Chg 3Y Avg | Lower P/Op Inc (Values for CDRE: 12.4% | 20.1x)

Higher Rev Chg LTM (Value for CDRE: 19.9%)

Higher Rev Chg 3Y Avg (Value for CDRE: 12.4%)

Higher Op Mgn LTM (Value for CDRE: 13.7%)

Higher CFO/Rev LTM (Value for CDRE: 10.7%)

Higher FCF/Rev LTM (Value for CDRE: 9.9%)

Higher Total Yield (Value for CDRE: 3.6%)

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

Top Gainers

Top Losers

Top Gainers

Top Losers

Top Gainers

Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Cadre

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

FDA Approved Drugs Data

Market Price (12/30/2025): $41.87 | Market Cap: $1.7 Bil
Sector: Industrials | Industry: Aerospace & Defense

Market Price (12/30/2025): $41.87
Market Cap: $1.7 Bil
Sector: Industrials
Industry: Aerospace & Defense